Fig. 3From: Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debateDimitri P. Mikhailidis is Reader and Honorary Consultant at the Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital Campus, University College London Medical School, University College London, London, UK. He is also Visiting Professor at the Robert Gordon University, Aberdeen, Scotland. His main clinical interest is vascular disease prevention, and his research interests include lipids and atherothrombosisBack to article page